Sidley Austin and Moelis & Company have advised ARCHIMED. Goodwin Procter and Centerview Partners have advised Esperion Therapeutics. Akin Gump has advised Pharmakon Advisors. ARCHIMED, a...
ARCHIMED Acquires Esperion Therapeutics in $1.1 Billion Transaction
Gilead to Acquire Tubulis in $5 Billion Oncology-Focused Transaction
Covington has advised Gilead Sciences, Inc. CMS and Goodwin Procter have advised Tubulis GmbH. Gilead Sciences, Inc. has entered into a definitive agreement to acquire Tubulis...
Novartis Acquires Pikavation Therapeutics and PI3K? Inhibitor Portfolio from Synnovation for Up to $3 Billion
Goodwin Procter and Mintz have advised Synnovation Therapeutics on the transaction. Novartis has entered into a definitive agreement to acquire Pikavation Therapeutics, Inc., a wholly-owned subsidiary...
Enavate Sciences Invests in Braveheart Bio’s $185 Million Series A Financing
Wilmer Cutler Pickering Hale and Dorr has advised Enavate Sciences. Goodwin Procter has advised Braveheart Bio. Enavate Sciences, a platform of Patient Square Capital, has made...
Thoma Bravo to Acquire Olo in $2 Billion All-Cash Transaction
Kirkland & Ellis LLP has advised Thoma Bravo on the transaction, and Goodwin Procter LLP has advised Olo Inc. Fried Frank acted as counsel to Goldman...
Helix Acquisition Corp. II’s US$949 Million Business Combination with BridgeBio Oncology Therapeutics
Goodwin Procter acted as legal counsel to BridgeBio Oncology Therapeutics, while White & Case acted as legal counsel to Helix Acquisition Corp. II on the transaction....
Jade Biosciences’ Merger with Aerovate Therapeutics
Gibson, Dunn & Crutcher advised Jade Biosciences on the transaction, and Cooley advised the placement agents; while Goodwin Procter advised Aerovate Therapeutics, Inc. Aerovate Therapeutics, Inc....
ARTBIO’s Exclusive Strategic Collaboration with AlphaGen Therapeutics
Goodwin is representing ARTBIO on the matter. AlphaGen Therapeutics (“AlphaGen”), a biopharmaceutical company, and ARTBIO, Inc., a clinical-stage radiopharmaceutical company developing a new class of targeted...
AVROBIO’s Merger with Tectonic Therapeutic
Leerink Partners is serving as exclusive financial advisor to Tectonic and Cooley LLP is serving as legal counsel to Tectonic. Leerink Partners and TD Cowen are...
Merck’s $680 Million Acquisition of Harpoon Therapeutics
Evercore Group L.L.C. acted as financial advisor to Merck in this transaction and Covington & Burling LLP acted as its legal advisor. Centerview Partners LLC acted...
HI-Bio’s $95 Million Series B Financing Round
Goodwin advised Human Immunology Biosciences (HI-Bio) on the round. Human Immunology Biosciences (HI-Bio™), a clinical-stage biotechnology company developing targeted therapies for patients with severe immune-mediated diseases (IMDs),...
Miro’s Acquisition of Freehand
Goodwin advised Miro in its acquisition of Freehand. Miro has acquired the visual collaboration platform, Freehand, from InVision. The deal includes the technology and brand assets, customer...